ESC Premium Access

Dalcetrapib reduces incident diabetes in patients with recent acute coronary syndrome

Congress Presentation

About the speaker

Professor Gregory Schwartz

University of Colorado School of Medicine, Aurora (United States of America)
2 presentations
0 follower

14 more presentations in this session

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

Speaker: Doctor C. Caselli (Pisa, IT)


Effects of evolocumab on LDL-C by race and ethnicity: an analysis of double-blind and open-label extension studies

Speaker: Doctor C. Rodriguez (The Bronx, US)


Therapeutic effect of nanoliposomal anti-PCSK9 vaccine on hypercholesterolemia and atherosclerosis in C57BL/6 mice.

Speaker: Professor M. Banach (Lodz, PL)


Nanoliposomal anti-PCSK9 vaccine induces long-term and safe protection against atherosclerosis in C57BL/6 mouse.

Speaker: Professor M. Banach (Lodz, PL)


Lipoprotein (a) and cardiovascular risk: are women at increased risk?

Speaker: Doctor M. Santos (Funchal, PT)


Access the full session

Poster Session 7 - Lipids

Speakers: Professor G. Schwartz, Doctor C. Caselli, Doctor C. Rodriguez, Professor M. Banach, Professor M. Banach...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb